This action might not be possible to undo. Are you sure you want to continue?

BooksAudiobooksComicsSheet Music### Categories

### Categories

### Categories

Editors' Picks Books

Hand-picked favorites from

our editors

our editors

Editors' Picks Audiobooks

Hand-picked favorites from

our editors

our editors

Editors' Picks Comics

Hand-picked favorites from

our editors

our editors

Editors' Picks Sheet Music

Hand-picked favorites from

our editors

our editors

Top Books

What's trending, bestsellers,

award-winners & more

award-winners & more

Top Audiobooks

What's trending, bestsellers,

award-winners & more

award-winners & more

Top Comics

What's trending, bestsellers,

award-winners & more

award-winners & more

Top Sheet Music

What's trending, bestsellers,

award-winners & more

award-winners & more

Welcome to Scribd! Start your free trial and access books, documents and more.Find out more

6 2-1

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

CHAPTER 2 Mathematics Review

Author: Michael Makoid, Phillip Vuchetich and John Cobby

Reviewer: Phillip Vuchetich

BASIC MATHEMATICAL SKILLS OBJECTIVES

1. Given a data set containing a pair of variables, the student will properly construct

(III) various graphs of the data.

2. Given various graphical representations of data, the student will calculate (III) the

slope and intercept by hand as well as using linear regression.

3. The student shall be able to interpret (V) the meaning of the slope and intercept

for the various types of data sets.

4. The student shall demonstrate (III) the proper procedures of mathematical and

algebraic manipulations.

5. The student shall demonstrate (III) the proper calculus procedures of integration

and differentiation.

6. The student shall demonstrate (III) the proper use of computers in graphical simu-

lations and problem solving.

7. Given information regarding the drug and the pharmacokinetic assumptions for

the model, the student will construct (III) models and develop (V) equations of the

ADME processes using LaPlace Transforms.

8. The student will interpret (IV) a given model mathematically.

9. The student will predict (IV) changes in the final result based on changes in vari-

ables throughout the model.

10. The student will correlate (V) the graphs of the data with the equations and mod-

els so generated.

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-2

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.1 Concepts of Mathematics

Pharmacokinetcs is a challenging field involving the application of mathematical

concepts to real situations involving the absorbtion, distribution, metabolism and

excretion of drugs in the body. In order to be successful with pharmacokinetics, a

certain amount of mathematical knowledge is essential.

This is just a review.

Look it over. You should

be able to do all of these

manipulations.

This chapter is meant to review the concepts in mathematics essential for under-

standing kinetics. These concepts are generally taught in other mathematical

courses from algebra through calculus. For this reason, this chapter is presented as

a review rather than new material. For a more thorough discussion of any particu-

lar concept, refer to a college algebra or calculus text.

Included in this section are discussions of algebraic concepts, integration/differen-

tiation, graphical analysis, linear regression, non-linear regression and the LaPlace

transform. Pk Solutions is the computer program used in this course.

Something new -

LaPlace transforms.

Useful tool.

A critical concept introduced in this chapter is the LaPlace transform. The LaPlace

transform is used to quickly solve (integrate) ordinary, linear differential equa-

tions. The Scientist by Micromath Scientific Software, Inc.

1

is available for work-

ing with the LaPlace transform for problems throughout the book.

1. MicroMath Scientific Software, Inc., P.O. Box 21550, Salt Lake City, UT 84121-0550,

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-3

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2 Mathematical Preparation

2.2.1 ZERO AND INFINITY

Any number multiplied by zero equals zero. Any number multiplied by infinity

equals infinity. Any number divided by zero is mathematically undefined.

Any number divided by infinity is mathematically undefined.

2.2.2 EXPRESSING LARGE AND SMALL NUMBERS

Large or small numbers can be expressed in a more compact way using indices.

How Does Scientific

Notation Work?

Examples: 316000 becomes

0.00708 becomes

In general a number takes the form:

Where A is a value between 1 and 10, and n is a positive or negative integer

The value of the integer n is the number of places that the decimal point must be

moved to place it immediately to the right of the first non-zero digit. If the decimal

point has to be moved to its left then n is a positive integer; if to its right, n is a

negative integer.

Because this notation (sometimes referred to as “Scientific Notation”) uses indi-

ces, mathematical operations performed on numbers expressed in this way are sub-

ject to all the rules of indices; for these rules see Section 2.2.4.

A shorthand notation (AEn) may be used, especially in scientific papers. This may

be interpreted as , as in the following example:

2.28E4 =

∞ ( )

3.16 10

5

×

7.08

3 –

×10

A 10

n

×

A 10

n

×

2.28

4

×10 22800 =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-4

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.3 SIGNIFICANT FIGURES

A significant figure is any digit used to represent a magnitude or quantity in the

place in which it stands. The digit may be zero (0) or any digit between 1 and 9.

For example:

How do I determine the

number of significant

figures?

Examples (c) to (e) illustrate the exceptions to the above general rule. The value 10

raised to any power, as in example (c), does not contain any significant figures;

hence in the example the four significant figures arise only from the 10.65. If one

or more zeros immediately follow a decimal point, as in example (e), these zeros

simply serve to locate the decimal point and are therefore not significant figures.

The use of a single zero preceding the decimal point, as in examples (d) and (e), is

a commendable practice which also serves to locate the decimal point; this zero is

therefore not a significant figure.

What do significant fig-

ures mean?

Significant figures are used to indicate the precision of a value. For instance, a

value recorded to three significant figures (e.g., 0.0602) implies that one can reli-

ably predict the value to 1 part in 999. This means that values of 0.0601, 0.0602,

and 0.0603 are measurably different. If these three values cannot be distinguished,

they should all be recorded to only two significant figures (0.060), a precision of 1

part in 99.

After performing calculations, always “round off” your result to the number of sig-

nificant figures that fairly represent its precision. Stating the result to more signifi-

cant figures than you can justify is misleading, at the very least!

TABLE 2-1 Significant Figures

Value

Significant

Figures

Number of

Significant

Figures

(a) 572 2,5,7 3

(b) 37.10 0,1,3,7 4

(c)

10.65 x 10

4

0,1,6,5 4

(d) 0.693 3,6,9 3

(e) 0.0025 2,5 2

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-5

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.4 RULES OF INDICES

What is an index? An index is the power to which a number is raised. Example: where A is a

number, which may be positive or negative, and n is the index, which may be pos-

itive or negative. Sometimes n is referred to as the exponent, giving rise to the

general term, “Rules of Exponents”. There are three general rules which apply

when indices are used.

(a) Multiplication

(b) Division

(c) Raising to a Power

There are three noteworthy relationships involving indices:

(i) Negative Index

As n tends to infinity then .

(ii) Fractional Index

(iii) Zero Index

A

n

A

n

A

m

A =

n m +

× A

n

B

m

×

A

B

---

. ,

| `

n

B ×

n m +

=

A

n

A

m

------- A

n m –

=

A

n

B

m

-------

A

B

---

. ,

| `

n

B ×

n m –

=

A

n

( )

m

A

nm

=

A

n – 1

A

n

------ = n ∞ → ( ) A

n –

0 →

A

1

n

---

A

n

=

A

0

1 =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-6

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.5 LOGARITHMS

What is a logarithm? Some bodily processes, such as the glomerular filtration of drugs by the kidney,

are logarithmic in nature. Logarithms are simply a way of succinctly expressing a

number in scientific notation.

In general terms, if a number (A) is given by

then

where ‘log’ signifies a logarithm to the base 10, and is the value of the logarithm

of (A).

Example: 713000 becomes ,

and , thus 713000 becomes

and

Logarithms to the base 10 are known as Common Logarithms. The transformation

of a number (A) to its logarithm (n) is usually made from tables, or on a scientific

calculator; the reverse transformation of a logarithm to a number is made using

anti-logarithmic tables, or on a calculator.

What is the characteris-

tic? the mantissa?

The number before the decimal point is called the characteristic and tells the place-

ment of the decimal point (to the right if positive and to the left if negative). The

number after the decimal is the mantissa and is the logarithm of the string of num-

bers discounting the decimal place.

2.2.6 NATURAL LOGARITHMS

What is a natural loga-

rithm?

Instead of using 10 as a basis for logarithms, a natural base (e) is used. This natural

base is a fundamental property of any process, such as the glomerular filtration of a

drug, which proceeds at a rate controlled by the quantity of material yet to undergo

the process, such as drug in the blood. To eight significant figures, the value of the

transcendental function, e, is

... Strictly speaking, Where is an inte-

ger ranging from 1 to infinity ,

A 10

n

= A ( ) log n =

n

7.13 10

5

×

7.13 10

0.85

= 10

0.85

10

5

× 10

5 0.85 + ( )

10

5.85

= =

713000 ( ) log 5.85 =

e 2.7182818 = e 1

1

x!

----

x 1 =

∞

∑

+ = x

∞ ( )

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-7

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

denotes the summation from , and

! is the factorial (e.g., 6! = 6x5x4x3x2x1= 720)

In general terms, if a number (A) is given by , then by definition,

Where, ‘ln’ signifies the natural logarithm to the base , and is the value of the

natural logarithm of .

Natural logarithms are sometimes known as Hyperbolic or Naperian Logarithms;

again tables are available and scientific calculators can do this automatically. The

anti-logarithm of a natural logarithm may be found from exponential tables, which

give the value of for various values of n.

How are natural loga-

rithms and common

logarithms related?

Common and natural logarithms are related as follows:

, and

Because logarithms are, in reality, indices of either 10 or , their use and manipu-

lation follow the rules of indices (See Section 2.2.4).

(a) Multiplication:

To multiply , where and ; .

By definition, ; but

and , hence

Thus, to multiply two numbers (N and M) we take the natural logarithms of each,

add them together, and then take the anti-logarithm (the exponent, in this case) of

the sum.

x 1 =

∞

∑

x 1 to x ∞ = =

A e

n

=

A ( ) ln n =

e n

A

e

n

x ln

x log

A ( ) ln 2.303 A ( ) log × =

A ( ) log 0.4343 A ( ) ln × =

e

N M × N e

n

= M e

m

= NM e

n

e

m

× e

n m +

= =

NM ( ) ln n m + =

n N ( ) ln = m M ( ) ln = NM ( ) ln N ( ) ln M ( ) ln + =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-8

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

(b) Division

(c) Number Raised to a Power

There are three noteworthy relationships involving logarithms:

(i) Number Raised to a Negative Power

As tends to infinity , then

(ii) Number Raised to a Fractional Power

(iii) Logarithm of Unity

N

M

-----

. ,

| `

ln N ( ) ln M ( ) ln – =

N

m

( ) ln m N ( ) ln × =

N

m –

( ) ln m N ( ) ln × – m

1

N

--- -

. ,

| `

ln × = =

m m ∞ → ( ) N

m –

( ) ln ∞ – →

N

m

( ) ln N

1

m

----

. ,

| `

ln

1

m

---- N ( ) ln × = =

1 ( ) ln 1 ( ) log 0 = =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-9

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.7 NEGATIVE LOGARITHMS

The number 0.00713 may be expressed as:

, or

, or

.

Hence, , which is the result generated by most calculators.

However, another representation of a negative logarithm (generally used by refer-

encing a log table):

log (0.00713) = 3.85

The 3 prior to the decimal point is known as the characteristic of the logarithm; it

can be negative (as in this case) or positive, but is never found in logarithmic

tables. The .85 following the decimal point is known as the mantissa of the loga-

rithm; it is always positive, and is found in logarithmic tables.

In fact 3 is a symbolic way of writing minus 3 (-3) for the characteristic. In every

case the algebraic sum of the characteristic and the mantissa gives the correct

value for the logarithm.

Example: log (0.00713) = 3.85

Add -3 and 0.85

Result is -2.15, which is the value of

The reason for this symbolism is that only positive mantissa can be read from anti-

logarithmic tables, and hence a positive mantissa must be the end result of any log-

arithmic manipulations. Note that while there are negative logarithms (when N <

1), they do not indicate that number itself is negative; the sign of a number (e.g., -

N) is determined only by inspection following the taking of anti-logarithms.

7.13

3 –

×10

10

0.85

10

3 –

×

10

2.15 –

0.00713 ( ) log 2.15 – =

0.00713 ( ) log

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-10

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.8 USING LOGARITHMIC AND ANTI-LOGARITHMIC TABLES

Though the preferred method to using logarithms is with a calculator or computer,

the understanding of how the number is being manipulated may be important in

understanding the use of logarithms. (See the end of this chapter for Logarithm

tables).

(a) Find the log of (62.54):

1. convert 62.54 to scientific notation ---> ;

2. Look up the mantissa for 6254 in a table of logarithms: it is 7962.

3. Hence, and

(b) Find the log of (0.00329)

1.

2. The mantissa for 329 is 5172

3. Hence, log(0.00329) = 3.5172.

Note that in both examples the value of the characteristic is the integer power to

which 10 is raised when the number is written in scientific notation.

How do I multiply using

logarithms?

(c) Multiply 62.54 by 0.00329

log (62.54) = 1.7972

log (0.00329) = 3.5172

log (62.54 + log (0.00329) = 1.7962+3.5172 = 1.7962-3+ 0.5172=-0.6866

0.6866=1.3134

(d) We wish to find anti-log (1.3134) Look up the anti-log for the 0.3134 (man-

tissa) in a table: it is 2058.

Antilog (1.3134) =

Hence, antilog (1.3134) = 0.2058

How do I divide using

logarithms?

log (62.54) - log (0.00329) = 1.796 - 3.5172=1.796 +3 - 0.5172=4.2788

antilog 4.2788 = 19002

62.54 6.254

1

×10 =

6.254

1

×10 10

0.7962

10

1

× 10

1.7962

= = 62.54 ( ) log 1.7962 =

0.00329 3.29

3 –

×10 =

2.058

1 –

×10

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-11

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.9 DIMENSIONS

What is a unit? There are three fundamental dimensions which are used in various combinations to

express the properties of matter. Each of these dimensions has been assigned a def-

inite basic unit, which acts as a reference standard.

How are units made big-

ger and smaller?

In the metric system, which emerged from the French Revolution around 1799,

there are various prefixes which precede the basic units and any derived units. The

prefixes indicate the factor by which the unit is multiplied. When the index of the

factor is positive the prefixes are Greek and have hard, consonant sounds. In con-

trast, when the index is negative, the prefixes are Latin and have soft, liquid

sounds. (see Table 2-3).

How big is big? Examples: An average adult male patient is assumed to have a mass of 70 kilo-

grams (70 kg). An average adult male patient is assumed to have a height of 180

centimeters (180 cm). A newly minted nickel has a mass of 5.000 g. Doses of

drugs are in the mg (10

-3

g) range (occasionally g) never Kg (10

3

g) or larger. Stu-

dents have told me that the dose that they have calculated for their patient is 10

8

g

(converting to common system - ~ 100 tons). I doubt it. Get familiar with this sys-

tem. Note that the plural of Kg or cm is Kg or cm; do not add an “s”. In pharmacy

there are two derived units which are commonly used, even though they are

related to basic units. The Liter (L) is the volume measurement and is a cube 10

cm on a side (1L = (10cm)

3

= 1000 cm

3

) while the concentration measurement

and has the units of Mass per Volume.

Why should I use units? Whenever the magnitude of a measured property is stated, it is imperative to state

the units of the measurement. Numbers are useless by themselves.

Example: The procainamide concentration range is 4-8 g/ml; stating the range

without units may lead to a potentially lethal error in which procainamide is

administered in a sufficient dose to attain a range of 4-8 mg/ml, which is 1000

times too large and would give rise to cardiac arrest.

TABLE 2-2 Dimensions

Dimension

Dimensional

Symbol Unit Unit Symbol

Length L meter m

Mass M gram g

Time T second sec

µ

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-12

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

TABLE 2-3 Scale of Metric system and SI

Name Symbol Multiplication Factor Name Symbol Multiplication Factor

exa- E deci- d

peta- P centi- c

tera- T milli- m

giga- G micro-

mega- M nano- n

kilo- k pico- p

hecto- h femto- f

deca- da atto- a

TABLE 2-4

Dimension

Dimensional

Symbol Unit

Unit

Symbol

Volume V liter l

Concentration C grams/liter g/l

10

18

10

1 –

10

15

10

2 –

10

12

10

3 –

10

9

µ

10

6 –

10

6

10

9 –

10

3

10

12 –

10

2

10

15 –

10

1

10

18 –

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-13

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.2.10 DIMENSIONAL ANALYSIS

How are units useful? It is a general rule that the net dimensions (and units) on the two sides of any equa-

tion should be equal. If this is not so, the equation is necessarily meaningless.

Consider the following equation which defines the average concentration of a drug

in blood after many repeated doses,

Where:

• is the fraction of the administered dose ultimately absorbed (Dimensions: none),

• is the mass of the repeated dose (Dimension: M),

• is the apparent volume of distribution of the drug (Dimension: )

• is the apparent first-order rate constant for drug elimination (Dimension: ),

• and is the dosing interval (Dimension: )

Writing the dimensions relating to the properties of the right-hand side of the equa-

tion gives:

Thus has the dimensions of , which are correctly those of concentration.

Sometimes dimensional analysis can assist an investigator in proposing equations

which relate several properties one with the other. If the units cancel, and you end

up with the correct unit of measure, you probably did it right. If you obtain units

that do not make sense, it’s guaranteed sure that you did it wrong.

C

b

( )

∞

FD

VKτ

---------- - =

F

D

V V L =

K T

1 –

τ T

M

V T

1 –

T ⋅ ⋅

------------------------

M

V

----- =

C

b

( )

∞

M

V

---- -

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-14

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.3 Calculus

What is Calculus? Calculus concerns either the rate of change of one property with another (differen-

tial calculus), such as the rate of change of drug concentrations in the blood with

time since administration, or the summation of infinitesimally small changes (inte-

gral calculus), such as the summation of changing drug concentrations to yield an

assessment of bioavailability. In this discussion a few general concepts will be pro-

vided, and it is suggested an understanding of graphical methods should precede

this discussion.

2.3.1 DIFFERENTIAL CALCULUS

2.3.2 NON-LINEAR GRAPHS

Consider the following relationship:

As can be seen from the graph (Figure 2-1), a non-linear plot is produced, as

expected.

FIGURE 2-1. y=x

3

(Question: How could the above data be modified to give a linear graph?)

TABLE 2-5 x, y sample data

x 0 1 2 3 4

y 0 1 8 27 64

y x

3

=

0

10

20

30

40

50

60

70

1 2 3 4

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-15

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.3.3 SLOPE OF NON-LINEAR GRAPH

As with a linear graph,

Where is the incremental change in y and is the incremental change in x

But, as can be seen (Figure 1), the slope is not constant over the range of the graph;

it increases as x increases. The slope is a measure of the change in y for a given

change in x. It may then be stated that:

“the rate of change of y with respect to x varies with the value of x.”

2.3.4 VALUE OF THE SLOPE

We need to find the value of the slope of the line when (See Figure

1). Hence, we may choose incremental changes in x which are located around

.

As may be seen, the value of the slope tends towards a value of 12.000 as the

magnitude of the incremental change in x becomes smaller around the chosen

value of 2.0. Were the chosen incremental changes in x infinitesimally small, the

true value of the slope (i.e., 12.000) would have appeared in the final column of

the above table.

y

2

y

1

–

x

2

x

1

–

----------------

y ∆

x ∆

------ =

y ∆ x ∆

FIGURE 2-2. / when

0 4 4 0 64 64 16.000

1 3 2 1 27 26 13.000

1.5 2.5 1.0 3.375 15.625 12.250 12.250

1.8 2.2 0.4 5.832 10.648 4.816 12.040

1.9 2.1 0.2 6.859 9.261 2.042 12.010

1.95 2.05 0.1 7.415 8.615 1.200 12.003

y x

3

= x 2 =

x 2 ≈

y ∆ x ∆ x 2 ≈

x

1

x

2 x ∆

y

1

y

2 y ∆

y ∆

x ∆

------

y ∆

x ∆

------

. ,

| `

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-16

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Calculus deals with infinitesimally small changes. When the value of is infini-

tesimally small it is written dx and is known as the derivative of x. Hence,

Where dy/dx is the derivative of y with respect to x and indicates some func-

tion of x.

2.3.5 DIFFERENTIATION FROM FIRST PRINCIPLES

Differentiation is the process whereby the derivative of y with respect to x is

found. Thus the value of dy/dx, in this case, is calculated.

(a) Considering again the original expression:

(b) Let the value of y increase to because x increases to .

Hence,

(EQ 2-13)

Multiplying out:

(EQ 2-14)

(c) The change in y is obtained by subtraction of the original expression from the

last expression. (i.e., Eq. 2 - Eq. 1)

(EQ 2-15)

Dividing throughout to obtain the derivative,

When dx is infinitesimally small, its magnitude tends to zero . The limit-

ing value of this tendency must be . At this limit,

x ∆

dy

dx

------ f x ( ) =

f x ( )

y x

3

=

y dy + x dx +

y dy + x dx + ( )

3

=

y dy + x

3

3x

2

dx ( ) 3x dx ( )

2

dx ( )

3

+ + + =

dy 3x

2

dx ( ) 3x dx ( )

2

dx ( )

3

+ + =

dy

dx

------ 3x

2

3x dx ( ) dx ( )

2

+ + =

dx 0 → ( )

dx 0 =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-17

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

(EQ 2-16)

Hence the derivative of y with respect to x at any value of x is given by .

(d) In section 2.3.4 we saw how the true value of the slope (i.e., dy/dx) would be

12.0 when . This is confirmed by substituting in Equation 1-16.

2.3.6 RULE OF DIFFERENTIATION

Although the rate of change of one value with respect to another may be calculated

as above, there is a general rule for obtaining a derivative.

Let x be the independent variable value, y be the dependent variable value, A be a

constant, and n be an exponential power.

The general rule is:

If

then

The Rules of Indices may need to be used to obtain expressions in the form

(e.g., if )

2.3.7 THREE OTHER DERIVATIVES

(a) If ,

then (i.e., is constant)

dy

dx

----- - 3x

2

=

3x

2

x 2 =

dy

dx

------ 3x

2

3 2

2

( ) 12 = = =

y Ax

n

=

dy

dx

------ nAx

n 1 –

=

y Ax

n

=

y x

5

=

y Ax

0

=

y A = y

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-18

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Hence,

Thus the derivative of a constant is always zero.

(b) Accept that if

then .

This derivative is important when considering apparent first-order processes, of

which many bodily processes (e.g., excretion of drugs) are examples.

(c) Accept that if where B and A are constants, and e is the natural

base then

This derivative will be useful in pharmacokinetics for finding the maximum and

minimum concentrations of drug in the blood following oral dosing.

2.3.8 A SEEMING ANOMALY

Consider the following two expressions:

(a) If , then

(b) If ,

then

Both of the original expressions, although different, have the same derivative. This

fact is recognized later when dealing with integral calculus.

dy

dx

------ 0 =

y x ( ) ln =

dy

dx

------

1

x

--- =

y Be

Ax

=

dy

dx

------ ABe

Ax

=

y Ax

n

=

dy

dx

------ nAx

n 1 –

=

y Ax

n

A + =

dy

dx

------ nAx

n 1 –

0 + nAx

n 1 –

= =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-19

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.3.9 INTEGRAL CALCULUS

Generally integral calculus is the reverse of differential calculus. As such it is used

to sum all the infinitesimally small units (dy) into the whole value (y).

Thus,

, where the symbol for integration.

2.3.10 RULE OF INTEGRATION

The derivative expression may be written:

, or

To integrate,

A general rule states:

Where A is the constant of integration However, there is one exception - the rule

is not applicable if

Example: If (See section 2.3.5),

then , and

y d

∫

y = is

∫

dy

dx

------ Ax

n

=

dy Ax

n

dx ⋅ =

y y d

∫

Ax

n

x d

∫

A x

n

x d

∫

= = =

A x

n

x d

∫

Ax

n 1 +

n 1 +

---------------- A + =

n 1 – =

dy

dx

------ 3x

2

=

y

3x

2 1 +

2 1 +

--------------- A + =

y x

3

A + =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-20

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.3.11 THE CONSTANT OF INTEGRATION

There has to be a constant in the final integrated expression because of the seeming

anomaly referred to in section 2.3.8. As mentioned, both and

will give, on differentiation, .

So whether or not a constant is present and, if so, what is its value, can only be

decided by other knowledge of the expression. Normally this other knowledge

takes the form of knowing the value of y when .

In the case of our graphical example we know that when , then . The

integrated expression for this particular case is:

, therefore

, thus

In some examples, such as first-order reaction rate kinetics, the value of A is not

zero.

2.3.12 THE EXCEPTION TO THE RULE

It occurs when

Upon integration,

This is the reverse of the derivative stated in section 2.3.10 (b).

2.3.13 A USEFUL INTEGRAL

Accept that if,

y x

3

= y x

3

A + =

dy

dx

----- - 3x

2

=

x 0 =

x 0 = y 0 =

y x

3

A + =

0 0

3

A + = A 0 =

n 1 – =

y A x

1 –

x d

∫

A

1

x

--- x d

∫

= =

y A x ( ) ln A + ⋅ =

dy

dx

------ Be

Ax

=

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-21

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

then,

This integral will be useful for equations which define the bioavailability of a drug

product.

2.3.14 EXAMPLE CALCULATIONS

(a) Consider,

Where is the drug concentration in a dissolution fluid at time .

Then, multiplying out,

The rate of dissolution at time t is

So at any time, the rate may be calculated.

(b) Consider,

Then rearranging,

The integral of is:

y

Be

Ax

A

----------- A + =

c 3t

2

t 2 – ( ) 5 + =

c t

c 3t

3

6t

2

– 5 + =

dc

dt

------ 9t

2

12t – =

dc

dt

------ 3t t 4 – ( ) 9t

2

12t – = =

dc 9t

2

dt 12 dt ⋅ – ⋅ =

c

c c d

∫

3t

3

A 6t

2

– B + + = =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-22

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

where is a second constant.

Adding the two constants together,

where

We know, from previous work, that when , then

Substituting , the final expression becomes:

Which is the initial expression in example (a) above.

(c) Following administration of a drug as an intravenous injection,

Where is the plasma concentration of a drug at time

is the apparent first-order rate constant of elimination.

Rearranging,

This integral is the exception to the rule (see section 2.3.12).

We know that when , .

B

c 3t

3

6t

2

D + = =

D A B + =

t 0 = c 5 =

5 D =

c 3t

2

6t

2

5 + + =

dC

p

–

dt

------------- KC

p

=

C

p

t

K

K – dt ⋅

1

C

p

------ dC

p

⋅ =

Kt – K t d

∫

–

1

C

p

------

∫

C

p

d ⋅ = =

Kt – C

p

( ) ln A + =

t 0 = C

p

C

p

( )

0

=

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-23

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Substituting,

Or,

Hence

or,

or,

0 C

p

( )

0

ln A + =

A C

p

( )

0

ln – =

Kt – C

p

( ) ln C

p

( )

0

ln – =

C

p

( ) ln C

p

( )

0

ln Kt – =

C

p

C

p

( )

0

e

Kt –

⋅ =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-24

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.4 Graphs

Why do we graph? We would like to organize the chaotic world around us so that we can predict (see

into the future) and retrodict (see into the past) what will happen or has happened.

Our recorded observations are collectively known as data. We make a theory

about what we think is happening and that theory is expressed in an equation. That

determines our paradigm of how we see the world. This paradigm is expressed as

a graph. The language of science is mathematics and graphs are its pictures.

What is a graph? A graph is simply a visual representation showing how one variable changes with

alteration of another variable. The simplest way to represent this relationship

between variables is to draw a picture. This pictorializing also is the simplest way

for the human mind to correlate, remember, interpolate and extrapolate perfect

data. An additional advantage is it enables the experimenter to average out small

deviations in experimental results (non-perfect, real data) from perfect data. For

example:

TABLE 2-6

English Science

Observations Data

Theory Equations

Paradigms (pictures) Graphs

TABLE 2-7 Perfect vs. Real data

Perfect Real

-3 -5 -4.6

-2 -3 -3.4

-1 -1 -0.6

0 +1 +0.8

+1 +3 +3.4

+2 +5 +4.4

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-25

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

FIGURE 2-3. Plot of Perfect vs. Real data

Simply looking at the columns x and y (real) it might be difficult to see the rela-

tionship between the two variables. But looking at the graph, the relationship

becomes apparent. Thus, the graph is a great aid to clear thinking. For every graph

relating variables, there is an equation and, conversely for every equation there is a

graph. The plotting of graphs is comparatively simple. The reverse process of find-

ing an equation to fit a graph drawn from experimental data is more difficult,

except in the case of straight lines.

2.4.1 GRAPHICAL CONVENTIONS

How are graphs made? Certain conventions have been adopted to make the process of rendering a data set

to a graphical representation extremely simple.

The ‘y’ variable, known as the dependent variable, is depicted on the vertical axis

(ordinate); and the ‘x’ variable, known as the independent variable, is depicted on

the horizontal axis (abscissa). It is said that ‘y’ varies with respect to ‘x’ and not

‘x’ varies with ‘y’.

A decision as to which of the two related variables is dependent can only be made

be considering the nature of the experiment. To illustrate, the plasma concentration

of a drug given by IV bolus depends on time. Time does not depend on the plasma

concentration. Consequently, plasma concentration would be depicted on the ‘y’

axis and time on the ‘x’ axis.

x

-3 -2 -1 0 1 2

-6

-4

-2

0

2

4

6

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-26

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Any point in the defined space of the graph has a unique set of coordinates: 1) the

‘x’ value which is the distance along the ‘x’ axis out from the ‘y’ axis and always

comes first; and 2) the ‘y’ value which is the distance, along the ‘y’ axis up or

down from the ‘x’ axis, and always comes second. Several points are shown in

Figure 2. For example, (0,1) is on the line and (1,0) is not.

The intersection of x and y axis is the origin with the coordinates of (0,0). In two

dimensional spaces, the graph is divided into 4 quadrants from (0,0), numbered

with Roman numerals from I through IV. It should be readily apparent that the

coordinates for all points within a particular quadrant are of the same sign type i.e.,

A line (or curve) on a graph is made up of an infinite number of points, each of

which has coordinates that satisfy a given equation. For example, each point on the

line in Figure 2 is such at its coordinates fit the equation . That is for

any value of x (the independent variable), multiplying the x value by 2 and adding

1 results in the y value (the dependent variable).

2.4.2 STRAIGHT LINE GRAPHS

What is a straight line? A graph is a straight line (linear) only if the equation from which it is derived has

the form

Where:

• y = dependent variable

• x = independent variable

• m = slope of the straight line =

• b = the y intercept (when x = 0)

• or if the equation can be “linearized”, e.g.,

is not linear. However.

is of the same general form as:

TABLE 2-8 Quadrants on a cartesian graph

Quadrant II (-x, +y) Quadrant I (+x, +y)

Quadrant III (-x, -y) Quadrant IV (+x, -y)

y 2x 1 + =

y mx b + =

y ∆

x ∆

------

y′ b′e

mx′

= y′ ln b′ ln mx′ + =

y b mx + =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-27

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

and consequently a plot of (the dependent variable) versus (the indepen-

dent variable) will yield a straight line with a slope of and an intercept of .

Expressions of any other form are non linear. For example:

An expression relating the plasma concentration of a drug over time .

this relationship put in linear perspective yields:

, which is in the form

The graphs that yield a straight line are the ones with the ordinate being ,

and the abscissa being .

Any other combination of functions of and will be non-linear, e.g.,

• versus

• versus

• versus

The appropriate use of a natural logarithm in this case serves to produce linearity.

However, the use of logarithms does not automatically straighten a curved line in

all examples. Some relationships between two variables can never be resolved into

a single straight line, e.g.,

where or

(It is possible to resolve this equation into the summation of two linear graphs

which will be shown subsequently.)

y′ ln x′

m b′ ln

C

p

( ) t ( )

C

p

C

p0

e

Kt –

=

C

p

ln C

p0

ln Kt – =

y b mx + =

C

p0

ln

t

C

p

t

C

p

t

C

p

t ln

C

p

ln t ln

y k

0

k

1

x

n m – ( )

k

2

x

n m – 1 + ( )

… k

n

( )x

x

+ + + + =

n 2 n ; ≥ m 1 + =

C

p

K

a

FD

V K

a

K – ( )

------------------------- e

Kt

e

K

a

t –

– ( ) ⋅ =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-28

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.4.3 THE SLOPE OF A LINEAR GRAPH (M)

What is the slope of a

straight line?

From the equation a prediction may be made as to whether the slope is positive or

negative. In the previous example, the slope is negative, i.e:

The differences in both the y-values and the x-values may be measured graphically

to obtain the value of the slope, m. Then knowing the value of m, the value of

may be found.

FIGURE 2-4. Plasma Concentration of caffeine over time

TABLE 2-9 Sample data of caffeine elimination

(min)

12 3.75 1.322

40 2.80 1.030

65 2.12 0.751

90 1.55 0.438

125 1.23 0.207

173 0.72 -0.329

m K – =

t

C

p

µg

mL

--------

. ,

| `

C

p

ln

K

C

p

( )

0 50 100 150 200

Time (min)

10

-1

10

0

10

1

C

a

f

f

e

i

n

e

C

o

n

c

e

n

t

r

a

t

i

o

n

(

u

g

/

m

L

)

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-29

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.4.4 LINEAR REGRESSION: OBTAINING THE SLOPE OF THE LINE

The equation for a straight line is:

• y is the dependent variable

• x is the independent variable

• m is the slope of the line

• b is the intercept of the line

The equation for the slope of the line using linear regression is:

And the intercept is

Using the data from table 2-10 in the equation for the slope of the line

and the intercept would be . Note that this is

. In oder to find the , the anti-ln of must be taken. i.e.

TABLE 2-10 Linear Regression for data in table 2-9

12 1.322 144 15.864

40 1.030 1600 41.2

65 0.751 4225 48.815

90 0.438 8100 39.42

125 0.207 15625 25.875

173 -0.329 29929 -56.917

y m x b + ⋅ =

m

Σ x ( ) Σ y ( ) ⋅ ( ) n Σ x y ⋅ ( ) ⋅ ( ) –

Σ x ( ) [ ]

2

n Σ x

2

( ) ⋅ ( ) –

--------------------------------------------------------------------- =

b y m x ⋅ ( ) – =

X Y X

2

X Y ⋅

ΣX 505 = ΣY 3.239 =

ΣX

2

59623 =

ΣXY 114.257 =

ΣX ( )

2

255025 =

x

Σx

n

------ 4.167 = = y

Σy

n

------ 0.5398 = =

m

505 3.239 ⋅ ( ) 6 114.257 ⋅ ( ) –

255025 6 59623 ⋅ ( ) –

--------------------------------------------------------------------- 0.01014

·

– = =

b 0.5398 0.01014 – 4.167 ⋅ ( ) – 1.4229 = =

C ln C

p0

b

Cpo e

b

e

1.4229

4.15 = = =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-30

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

It is important to realize that you may not simply take any two data pairs in the

data set to get the slope. In the above data, if we simply took two successive data

pairs from the six data pairs in the set, this would result in five different slopes

ranging from -0.0066 to -0.0125 as shown in table 2-11. Clearly, this is

unacceptable. Even to guess, you must plot the data, eyeball the best fit line by

placing your clear straight edge through the points so that it is as close to the data

as possible and look to make sure that there are an equal number of points above

the line as below. Then take the data pairs from the line, not the data set.

2.4.5 PARALLEL LINES

Two straight lines are parallel if they have the same slope.

Calculating for the intercept of a linear graph (b):

(a) Not knowing the value of m; The graph may be extrapolated, or calcu-

lations performed, at the situation where . In this case .

(b) Knowing the value of m;

• There are two ways: for any point on the graph: and

Hence, b may be calculated from a knowledge of and .

• Secondly, the graph may be extrapolated or calculations performed, at the situation where

. In this case,

TABLE 2-11 Sample slope data from figure 2-4

Time (x) ln Conc. (y)

12 1.322 -28 0.292 -0.0104

40 1.030 -25 0.28 -0.0112

65 0.751 -25 0.312 -0.0125

90 0.438 -35 0.231 -0.0066

125 0.207 -48 0.536 -0.0112

173 -0.329

∆x ∆y ⁄ ( )

x ∆ y ∆

y ∆

x ∆

------

t 0 = b C

p0

ln =

y

1

mx

1

b + = b y

1

mx

1

– =

y

1

x

1

t 0 = b C

p

ln =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-31

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.4.6 GRAPHICAL EXTRAPOLATIONS

How far can I predict? It is dangerous to extrapolate on non-linear graphs, and it is unwise to extrapolate

too far on linear graphs. Most often extrapolation is used to find the value of y at a

selected value of x.

If the size of the graph does not permit physical extrapolation to the desired value,

the required result may be obtained by calculation. The values of m and b must be

found as shown above. Then: , where is the selected value of x,

and is the new calculated value for y.

2.4.7 SIGNIFICANCE OF THE STRAIGHT LINE

The more closely the experimental points fit the best line, and the higher the num-

ber of points, the more significant is the relationship between y and x. As you may

expect, statistical parameters may be calculated to indicate the significance.

What good is a straight

line?

By using all the experimental data points, calculations may be made to find the

optimum values of the slope m, and the intercept, b. From these values the corre-

lation coefficient (r).and the t-value may be obtained to indicate the significance.

Exact details of the theory are available in any statistical book, and the calculations

may most easily be performed by a computer using The Scientist or PKAnalyst in

this course.

The advantage of computer calculation is that it gives the one and only best fit to

the points, and eliminates subjective fitting of a line to the data.

2.4.8 GRAPHICAL HONESTY

How many points are

needed?

Any graph drawn from 2 points is scientifically invalid. Preferably, straight-line

graphs should have at least 3 - 5 points, and non-linear graphs a few points more.

Can I discard points that

don’t fit?

As a graph is a visual representation which enables the experimenter to average

out the small deviations in results from the “perfect” result, no one result can be

unjustifiably ignored when the best fitting line is drawn. Still, an “errant” point

may be justifiably ignored if there were unusual experimental circumstances

which may have caused the deviation. Thus it is not justifiable to omit a point

solely because it “does not fit”.

2.4.9 AXES WITH UNEQUAL SCALES

In mathematical studies, the scales of the x and y are almost always equal but very

often in plotting chemical relations the two factors are so very different in magni-

y' mx' b + = x'

y'

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-32

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

tude that this can not be done. Consequently, it must be borne in mind that the rela-

tionship between the variables is given by the scales assigned to the abscissa and

ordinate rather than the number of squares counted out from the origin.

FIGURE 2-5.

For example (shown in Figure 2-5), these two parabolic curves represent the same

equation the only difference is the scales are different along the y axis.

Frequently it is not convenient to have the origin of the graph coincide with the

lower left hand corner of the coordinate paper. Full utilization of the paper with

suitable intervals is the one criteria for deciding how to plot a curve from the

experimental data. For example, the curve below (Figure 2-6) is poorly planned,

where the following (Figure 2-7) is a better way of representing the gas law

0 2 4 6 8 10

0.00

0.05

0.10

0.15

0.20

0.25

0.30

0.35

y 0.1 x =

0 2 4 6 8 10

0

2

4

6

8

10

PV nRT =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-33

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

FIGURE 2-6. Poorly presented graph

FIGURE 2-7. Well arranged graph

2.4.10 GRAPHS OF LOGARITHMIC FUNCTIONS

Previously variables were raised to constant powers; as . In this section

constants are raised to variable powers; as . Equations of this kind in which

the exponent is a variable are called (naturally) exponential equations. The most

important exponential equation is where is plotted against .

0 4 8 12 16 20

0

10

20

30

40

50

1 2 3 4 5 6 7 8 9 10

P ( )

0

5

10

15

20

25

y x

2

=

y 2

x

=

e

x

x

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-34

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.4.11 SEMILOGARITHMIC COORDINATES

Exponential or logarithmic equations are very common in physical chemical phe-

nomenon. One of the best ways of determining whether or not a given set of phe-

nomenon can be expressed by a logarithmic or exponential equation is to plot the

logarithm of one property against another property. Frequently a straight line is

obtained and its equation can be readily found. For example:

In the following table the plasma concentration of the immunosuppressant

cyclosporine was measured after a single dose (4mg/kg) as a function of time.

These can be illustrated in three different ways (Figures 2-8, 2-9, 2-10),

• Concentration vs. time directly

• Log concentration vs. time directly

• Log concentration vs. time with concentration plotted directly on to log scale of ordinate.

FIGURE 2-8. Concentration (ng/ml) vs. time (hr)

TABLE 2-12 Plasma concentration of cyclosporine

Time (hours)

Concentration

0.25 1900

.75 1500

1.5 1300

4 900

6 600

8 390

D’mello et al., Res. Comm. Chem. Path. Pharm. 1989: 64 (3):441-446

C

p

( )

ng

ml

------

200

400

600

800

1000

1200

1400

1600

1800

2000

0 1 2 3 4 5 6 7 8

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-35

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

FIGURE 2-9. Log Concentration vs. time

FIGURE 2-10. Log concentration (on log scale) vs. time

Graphing is much easier because the graph paper itself takes the place of a loga-

rithmic table, as shown in Figure 1-10.

Only the mantissa is designated by the graph paper. Scaling of the ordinate for the

characteristic is necessary. The general equation can be expressed as a

straight line by basic laws of indices.

or

One axis is printed with logarithmic spacing, and the other with arithmetic spac-

ing. It is used when a graph must be plotted as in the example (Figure 1-4)

and .

Log Concentration - Time Curve

2.300

2.400

2.500

2.600

2.700

2.800

2.900

3.000

3.100

3.200

0 1 2 3 4 5 6 7 8

100

1000

10000

0 1 2 3 4 5 6 7 8

y Be

ax

=

y ln B ln e

ax

( ) ln + = y ln B ln ax + = → y ln ax B ln + =

y C

p

[ ] log = x t =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-36

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

In this example, the vertical logarithmic axis is labelled “Plasma concentration of

cyclosporine” and the values plotted are the ordinary values of . Thus, there is

no need to use logarithmic tables, because the logarithmic spacing is responsible

for obtaining a straight line.

Two problems may occur when graphing on a logarithmic mantissa:

a) there are not enough cycles to incorporate all the data

b) obtaining the value of the slope is difficult. In this instance the slope is given by:

Hence, before calculating the value of m, the two selected values of and

must be converted, using a calculator, to and in order to satisfy the

equation. The same problem may arise in obtaining the intercept value, b.

The two problems may be avoided by plotting the same data on ordinary paper, in

which case the vertical axis is labelled “log plasma concentration”. However, in

this instance the ordinary values of must be converted to prior to plot-

ting. It is the values which are then plotted.

The calculation of the slope is direct in this case, as the values of and may be

read from the graph. Hence, one must consider the relative merits of semilogarith-

mic and ordinary paper before deciding which to use when a log plot is called for.

In the case of semilog graphs the slope may be found in a slightly different manner,

i.e., taking any convenient point on the line we usually take the as the second

point, one half of . Thus,

(in which case, is called the half-life ). Since , then

because and .

C

p

[ ]

m

y

2

y

1

–

x

2

x

1

–

----------------

C

p

[ ]

2

ln C

p

[ ]

1

ln –

t

2

t

1

–

-------------------------------------------- = =

C

p

[ ]

1

C

p

[ ]

2

C

p

[ ]

1

ln C

p

[ ]

2

ln

C

p

[ ] C

p

[ ] ln

C

p

[ ] ln

y

1

y

2

y

1

( )

y

2

( ) y

1

( )

m

y ln

1

1 2 ⁄ ( )y

1

( ) ln –

t

1

t

2

–

-----------------------------------------------

y

1

1 2 ⁄ ( )y

1

--------------------

. ,

| `

ln

t

1

t

2

–

-------------------------------

1

1 2 ⁄

--------- -

. ,

| `

ln

t

1

t

2

–

---------------------

2 ln

t

1

t

2

–

--------------

0.693

t

1 2 ⁄

–

------------- = = = = =

t

2

t

1

– t

½

t

1

t

2

< t

1

t

2

– t

1 2 ⁄

– =

m

0.693

t

1 2 ⁄

–

------------- k – = = k

0.693

t

1 2 ⁄

------------- =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-37

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.4.12 LOG - LOG COORDINATES

Functions of the type give straight lines when plotted with logarithms

along both axis.

i.e., equation in logarithmic form is:

or which is in the form

. This is directly applicable to parabolic and hyperbolic equations

previously discussed (see Figure 1-5).

2.4.13 PITFALLS OF GRAPHING: POOR TECHNIQUE

The utility of these procedures requires proper graphing techniques. The picture

that we draw can cause formation of conceptualizations and correlations of the

data that are inconsistent with the real world based simply on a bad picture. Conse-

quently the picture must be properly executed.

The most common error is improper axes labelling. On a single axis of rectilinear

coordinate paper (standard graph paper), a similar distance between two points

corresponds to a similar difference between 2 numbers. Thus,

FIGURE 2-11. Graphing using standard number spacing

y Bx

a

=

y log B log a x log + = y log a x log b log + =

y mx b + =

0 5 10 15 20 25 30

0

10

20

30

40

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-38

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

FIGURE 2-12. Nonstandard (incorrect) graph

Obviously, the distance (Time) on the graph 12 between 0 and 2 hours should not

be the same as the distance between 10 and 20 hours. It is, and therefore Figure 2-

12 is wrong.

Similarly, the use of similar paper may result in some confusion. With logarithms

the mantissa for any string of numbers, differing only by decimal point placement,

is the same. What differentiates one number from another, in this case, is the char-

acteristic. Thus,

The paper automatically determines the relationship between strings of numbers

(mantissa) by the logarithmic differences between the numbers on the axis within a

cycle. The student must determine the order of magnitude (characteristic) to be rel-

egated to each cycle.

TABLE 2-13 Logarithmic graphing

Number Mantissa Characteristic Log

234 .3692 2 2.3692

23.4 .3692 1 1.3692

2.34 .3692 0 0.3692

0.234 .3692 -1 1.3692

0

0

2 5 10 20 30

1

10

20

30

40

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-39

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

FIGURE 2-13. Logarithmic mantissa

Thus, we see, in Figure 2-13, the cycle on the semilog paper to relate to orders of

magnitude (e.g., 1, 10, 100, 1000, etc.) and consequently the characteristic of the

exponent.

The third common problem is labelling the log axis as log “y”. This is improper. It

is obvious from the spacing on the paper that this function is logarithmic, and thus

the axis is simply labelled “y”.

There are almost as many different errors as there are students and it is impossible

to list them all. These few examples should alert you to possible problems.

2.4.14 GRAPHICAL ANALYSIS

We will look at several different types of plots of data:

FIGURE 2-14. Straight line going down on semi-log paper

234

23.4

2.34

0.234

1.0 1.5 2.0 2.5 3.0 3.5 4.0

X axis (units)

10

-1

10

0

10

1

10

2

10

3

Y

a

x

i

s

(

u

n

i

t

s

)

Logarithmic Plot

0 1 2 3 4 5

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-40

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Find the slope by taking any two values on the Y axis such that the smaller value is

one half of the larger. The time that it takes to go from the larger to the smaller is

the half-life. Dividing 0.693 by the half-life yields the rate constant.

Extrapolating the line back to yields the intercept.

FIGURE 2-15. Curved line which plateaus on semi-log paper.

FIGURE 2-16. Curved line which goes up and then straight down on semi-log paper.

Find the terminal slope by taking any two values on the Y axis such that the

smaller value is one half of the larger. The time that it takes to go from the larger to

the smaller is the half-life. Dividing 0.693 by the half-life yields the rate constant.

Plot type one is reasonably easily evaluated. There are 2 important things that can

be obtained: Slope and Intercept. However, the slope and intercept have different

meanings dependent on the data set type plotted. The slope is the summation of all

the ways that the drug is eliminated, -K.

t 0 =

0 2 4 6 8 10 12

0 5 10 15 20 25

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-41

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Plot type two is not usually evaluated in its present form as only the plateau value

can be obtained easily. But again it has different meanings dependent on the data

plotted.

Usually urine data of this type (parent compound - IV bolus) is replotted and eval-

uated as plot 1 (above). Infusion data can be replotted using the same techniques,

but usually is not.

Plot type 3 must be stripped of the second rate constant from the early time points,

thus:

There are 3 things that can be obtained from the plot: the terminal slope (the

smaller rate constant), the slope of the stripped line (the larger rate constant) and

the intercept. The rate constants obtained from a caternary chain (drug moving

from one box to another in sequence in compartmental modeling) are the summa-

tion of all the ways that the drug is eliminated from the previous compartment and

all the ways the drug is eliminated from the compartment under consideration. See

LaPlace Transforms for further discussion.

Again, dependent on the data set type being plotted they will have different values.

TABLE 2-14 Plot type 1 examples

Data Type Y axis X axis Slope Intercept

IV Bolus Parent Drug Conc. parent compound Time -K

IV Bolus Parent

urine rate of excretion

parent compound

Time

(mid)

-K

IV Bolus Parent

Cumulative urine

data

Time -K

TABLE 2-15 Plot Type 2 examples

Data Type Y axis X axis Plateau Value

IV Bolus Parent

Cumulative urine

data parent compound

Time

IV Infusion

Parent

Drug concentration

parent compound

Time

C

p0

dose

Vd

----------- =

dXu

dt

----------

Kr X

0

⋅

Xu

∞

Xu – kr

K X

0

⋅

--------------

Xu

Xu

∞

kr

K X

0

⋅

-------------- =

C

p

( )

ss

Q

K V ⋅

------------

Q

cl

---- = =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-42

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

TABLE 2-16 Plot Type 3 examples

Data

Type Y axis X axis S1 S2 Intercept

IV Bolus

Parent

Metabolite conc. Time -K

small

-K

large

IV Bolus

Parent

excretion

rate of metabolite

into urine

Time

(mid)

-K

small

-K

large

Oral Drug conc. Time -K

small

-K

large

km X

0

⋅

K

l e arg

K

smal l

– ( ) V

dm

⋅

-------------------------------------------------------

dXmu

dt

---------------

k

mu

k

m

X

0

⋅ ⋅

K

l e arg

K

smal l

–

------------------------------------

k

a

fX

0

⋅

K

l e arg

K

smal l

– ( ) V

d

⋅

----------------------------------------------------

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-43

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.5 Pharmacokinetic MoKdeling

It has been observed that, after the administration of a drug, the concentration of

the drug in the body appear to be able to be described by exponential equations.

Thus, it appears that, even though the processes by which the drug is absorbed. dis-

tributed, metabolized and excreted (ADME) may be very complex, the kinetics

(math) which mimics these processes is made up of relatively simple first order

processes and is called first order pharmacokinetics. A second observation is that

the resulting concentration is proportional to dose. When this is true, the kinetics is

called linear. When this math is applied to the safe and effective therapeutic man-

agement of an individual patient, it is called clinical pharmacokinetics. Thus, in

clinical pharmacokinetics, we monitor plasma concentrations of drugs and suggest

dosage regimens which will keep the concentration of drug within the desired ther-

apeutic range. Pharmacodynamics refers to the relationship between the drug con-

centration at the receptor and the intensity of pharmacological (or toxicological)

response. It is important to realize that we want to control the pharmacological

response. We do that indirectly by controlling the plasma concentration. In order

for this to work, we assume kinetic homogeneity, which is that there is a predict-

able relationship between drug concentration in the plasma (which we can mea-

sure) and drug concentration at the receptor site (which we can not measure). This

assumption is the basis for all clinical therapeutics.

Models are simply mathematical constructs (pictures) which seem to explain the

relationship of concentration with time (equations) when drugs are given to a per-

son (or an animal). These models are useful to predict the time course of drugs in

the body and to allow us to maintain drug concentration in the therapeutic range

(optimize therapy). The simplest model is the one used to explain the observations.

We model to summarize data, to predict what would happen to the patient given a

dosage regimen, to conceptualize what might be happening in disease states and to

compare products. In every case, the observations come first and the explanation

next. Given that a data set fits a model, the model can be used to answer several

different types of questions about the drug and how the patient handles the drug

(its disposition), for example: if the drug were to be given by an oral dose, how

much is absorbed and how fast? Are there things which might affect the absorp-

tion, such as food or excipients in the dosage form itself. What would happen if the

drug were to be given on a multiple dose regimen? What if we increased the dose?

etc.

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-44

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

You should be able to:

• be facile in the use of the equations. You should be able to graphically manipulate data sets and

extract pharmacokinetic parameters, applying the appropriate equations or variations of them.

• define all new words used in this section. e g.: Succinctly define, stating rigorously the meaning

of any symbols used and the dimensions of measurement.

• compare and contrast new concepts used in this section. e. g.: rate and rate constant, zero and

first order kinetics, bolus and infusion methods, excretion and elimination, the assumptions

made in pharmacokinetic models with physiological reality. Why can these assumptions be

made?

• pictorially represent any two variables (graph) one vs. the other. e.g. for each of the following

pairs of variables (ordinate against abscissa), draw a graph illustrating the qualitative profile of

their relationship. Where appropriate, indicate the nature of important slopes, intercepts, and

values. Unless you specifically indicate on your plot that semi-log paper is being considered

(write “S-L”), it will be assumed that rectilinear paper is being considered. Graphs are for a

drug given by IV Bolus where applicable.

2.5.1 MAKING A MODEL

The differential equations used result from the

model which is our conceptualization of what is

happening to the drug in the body.

The box (compartment) is the area of interest. We

want to find out how the mass of drug, , changes

with time in that compartment, the rate, and how the rates change with time, the

differential equations.

How do we make a dif-

ferential equation?

The picture that we build is made up of building blocks, consisting of the arrow

and what the arrow touches. The arrow demonstrates how quickly the mass of

drug, , declines. The arrow times the box that the arrow touches = the rate. Rates

can go in, i.e. arrows pointing to a box mean drug is going in (+ rate). Rates can go

out, i.e. arrows pointing away means drug is going out (- rate). Rate = rate constant

(arrow) times mass of drug (box). So the arrow and box really is a pictorial repre-

sentation of a rate where the rate is the rate constant on the top of the arrow times

what the tail of the arrow touches.

Again, the rate constant, , tells the magnitude of the rate, .

Consider the following simple chain:

X

k

a

X

X

k k X ⋅

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-45

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

The building blocks are and . Every arrow that touches the compart-

ment of interest becomes part of the differential equation. If the arrow goes to the

box, it’s positive; if it goes away from the box, it’s negative.

To find (the rate of change of with time), we simply add up all of the

rates which affect (all of the arrows that touch )

and thus:

(Note: the first subscript of the rate constant and the subscript of the box from

which it originates are the same.)

You should be able to develop the series of interdependent differential equations

which would result from any model. The integration of those equations by use of

the Laplace Table is done by transforming each piece of the equation into the

Laplace domain (looking it up on the table and substituting). The algebra per-

formed solves for the time dependent variable: put everything except the variable

(including the operator, s) on the right side and put the variable on the left. Find the

resulting relationship on the left side of the table. The corresponding equation on

the right side of the table in the integrated form.

You should be able to integrate any differential equation developed from any

model (within reason) that we can conceptualize.

(Note: Each subsequent variable is dependent on the ones that precedes it. In fact,

the solutions to the preceding variables are substituted into the differential to

remove all but one of the time dependent functions - the one that we are currently

attempting to solve.)

X

1

X

3

X

2

k

12

k

23

k

12

X

1

⋅ k

23

X

2

⋅

dX

1

dt ⁄ X

1

X

1

X

1

dX

1

dt

--------- k

12

X

1

⋅ – =

dX

2

dt

--------- k

12

X

1

k

23

X

2

⋅ – ⋅ =

dX

3

dt

--------- k

23

X

2

⋅ =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-46

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.5.2 ONE COMPARTMENT OPEN MODEL

A simplified picture (mathematical construct) of the way the body handles drug is

one where the body can be conceived to be a rapidly stirred beaker of water (a sin-

gle compartment). We put the drug in and the rate at which the drug goes away is

proportional to how much is present (first order). Thus the assumptions are:

• Body homogeneous (one compartment)

• Distribution instantaneous

• Concentration proportional to dose (linear)

• Rate of elimination proportional to how much is there. (First order)

It is important to note that we know some of these assumptions are not true. It is of

little consequence, as the data acts as if these were true for many drugs. The visual

image which is useful is one of a single box and a single arrow going out of the

box depicting one compartment with linear kinetics. The dose is placed in the box

and is eliminated by first order processes. In many cases, more complicated mod-

els (more boxes) are necessary to mathematically mimic the observed plasma ver-

sus time profile when one or more of these assumptions are not accurate. For

example, the two compartment (or multi-compartment) model results when the

body is assumed to not be homogeneous and distribution is not instantaneous.

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-47

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.6 The LaPlace Transform

Why do we need to

know the LaPlace trans-

form?

One of the important facets of biopharmaceutics is a familiarity with the principles

of pharmacokinetics. This latter discipline describes the study of the dynamic pro-

cesses by which the body “handles” or “disposes of” an administered drug. These

processes (absorption, distribution, metabolism, and excretion (ADME) are

dynamic in that they represent the time-dependent changes occurring to the drug.

Thus, in pharmacokinetics the time course of these changes, which overall

describe the fate of the administered drug, is described mathematically. If the

mathematical principles are understood, it is then possible to use pharmacokinetics

in clinical practice, such as the design of rational dosage regimens (T.S. Foster and

D.U.A. Bourne, Amer. J. Hosp. Pharm., 34, 70-75 (1977). Understanding

(Bloom’s level 4) is not simply memorizing (Bloom’s level 1) nor calculating

using a memorized equation (Bloom’s level 3). The authors believe that the proper

conceptualizing of the process and the subsequent derivation of the appropriate

equations will lead to an understanding of the mathematical principles, and thus, a

better, more optimal dosing regimen.

Since a mathematical description of the time-dependent ADME processes is

required, it becomes necessary to deal with their corresponding rate equations.

Inevitably this will involve calculus (mainly integral calculus). However, the

LaPlace Transform provides a method whereby calculus can be performed with

minimal trauma. If a conscientious effort to learn the method is made and applied,

a potentially serious obstacle (the fear of calculus) to the understanding and appre-

ciation of biopharmaceutics will be removed. Indeed, many students will find they

no longer fear integration and are thus free to comprehend the principles underly-

ing pharmacokinetics, which, after all, is the primary aim. So, the LaPlace Trans-

form is a tool which is of great assistance in pharmacokinetics; its utility and

importance should not be lightly disregarded.

The LaPlace Trans-

form: What Is It?

There is, of course, a theoretical background to the LaPlace Transform. However,

it can be used without recourse to a complete theoretical discussion, though appro-

priate pharmaceutical use of the method is found in the following references:

M. Mayersohn and M. Gibaldi, Amer. J. Pharm. Ed., 34, 608-614 (1970).

M. Gibaldi and D. Perrier, “Pharmacokinetics”, Marcel Dekker, pp. 267-272

(1975).

Basically, the LaPlace Transform is used to solve (integrate) ordinary, linear differ-

ential equations. In pharmacokinetics such equations are zero and first-order rate

equations in which the independent variable is time. For instance, if a differential

equation describing the rate of change of the mass of drug in the body with time is

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-48

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

integrated, the final equation will describe the mass of drug actually in the body at

any time.

The procedure used is to replace the Independent variable (time) by a function

containing the LaPlace Operator, whose symbol is “s”. In doing so we have

replaced the time domain by a complex domain. This is analogous to replacing a

number by its logarithm. Once in the complex domain, the transformed function

may be manipulated by regular algebraic methods. Then the final expression in the

complex domain is replaced by its equivalent in the time domain, yielding the inte-

grated equation. This ultimate process is analogous to taking an antilogarithm.

2.6.1 TABLE OF LAPLACE TRANSFORMS

A table of useful LaPlace

transforms is given in

Section 2.7. Page 2-56.

The replacement of expressions in one domain by their equivalents in another is

accomplished by reference to tables. One column shows time domain expressions,

stated as , and second column shows the corresponding complex domain

expressions, stated as the LaPlace Transform. Note that “ ” simply means

“some function of time”. For example, when is , then the LaPlace

Transform is , where “B” is a constant and “a” is a rate constant

For example, when the LaPlace Transform is , then is .

2.6.2 SYMBOLISM

For simplicity in writing transformed rate expressions (and to distinguish them

from untransformed (time domain) expressions), the following symbolism will be

employed:

“a bar will be placed over the dependent variable which is being transformed”.

Example:

If X is the mass of unchanged drug in the body at any time, then X is the LaPlace

Transform of this mass.

f t ( )

f t ( )

f t ( ) Be

at –

B s a + ( ) ⁄

A s

2

⁄ f t ( ) At

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-49

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.6.3 CONVENTIONS USED IN DRAWING PHARMACOKINETIC SCHEMA.

When drugs enter the body, they will encounter many different fates. It is impor-

tant to set up the possible fates of the drug by creating a well thought out flow

chart or scheme in order to follow all the events that are occurring in the body as

described by the pharmacokinetic description of the drug. For example, a drug

may be excreted unchanged or may undergo hepatic metabolism to yield active or

inactive metabolites. All of these components are part of pharmacokinetics, which

by definition, includes ADME (the Absorption, Distribution, Metabolism and

Excretion of drugs), and must be considered. This flow chart becomes the back-

bone or the framework upon which to build the equations which describe the phar-

macokinetics of the drug. The differential equations result as a direct consequence

of the flow chart. Using Laplace transforms, the integration of these differential

equations are simplified and provide the pharmacokineticist to (easily?) keep track

of all of the variables in the equation. If the drug scheme or flow chart is set up

incorrectly, this would have a definite negative impact or the expected equations

(as well as the answers and your grade). Below are two examples of how to con-

struct a flow chart. Note that not all drugs follow the same flow chart and it is

quite possible that you will need only to use a portion of these examples when con-

struction your own.

In general, schema are relatively consistent in the placement of the compartments

in relationship to one another. You might consider, for example a drug, given by

IV bolus, which is metabolized and both the metabolite and the parent compound

are excreted unchanged as shown below:

X Xu Xf

Xm Xmu Xmf

Parent Compound

Metabolite

Feces Body Urine

ku kf

km

kmf kmu

Dose

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-50

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Using the pharmacokinetic symbolism from chapter one, the compartments are

named and placed: metabolites below (or above the plane of the parent com-

pound): compounds going into the urine, to the right; and compounds going into

the feces, to the left of the compounds in the body. The rate constants connecting

the compartments also follow the symbolism from chapter one. In the above flow

chart, K, the summation of all the ways that X is removed from the body, is ku + kf

+ km while K1, the summation of all the ways that Xm is removed from the body,

is kmu +kmf.

Only those compartments are used which correspond to the drug’s pharmacoki-

netic description, thus when a drug is given by IV bolus and is 100% metabolized

with the metabolite being 100% excreted into the urine the model would look like

this:

Thus in this flow chart, K, the summation of all the ways that X is removed from

the body, is km while K1, the summation of all the ways that Xm is removed from

the body, is kmu.

X

Xm Xmu

km

kmu

Dose

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-51

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Drugs sometimes are metabolized to two (or more) different metabolites. In the

first case, the drug is metabolized by two separate pathways resulting in this flow

chart:

In this flow chart, K, the summation of all the ways that X is removed from the

body, is ku + kf + km1 + km2 while K1, the summation of all the ways that Xm1 is

removed from the body, is kmu1 +kmf1 and K3, the summation of all the ways

that Xm2 is removed from the body, is kmu2 + kmf2.

While in a second case, the drug is metabolized and the metabolite is further

metabolized resulting in this flow chart:

X

Xm1

Xm2

km1

km2

Xmu1

Xu

Xmu2

ku

kmu1

kmu2 kmf2

kf

kmf1 Xmf1

Xf

Xmf2

Dose

X

Xm1

Xm2

km1

km2

Xmu1

Xu

Xmu2

ku

kmu1

kmu2 kmf2

kf

kmf1

Xmf1

Xf

Xmf2

Dose

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-52

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

In this flow chart, K, the summation of all the ways that X is removed from the

body, is ku + kf + km1 while K1, the summation of all the ways that Xm1 is

removed from the body, is kmu1 +kmf1+ km2 and K3, the summation of all the

ways that Xm2 is removed from the body is kmf2 + kmu2.

Both of these flow charts result in very different end equations, so it is imperative

that the flow charts accurately reflect the fate of the drug.

2.6.4 STEPS FOR INTEGRATION USING THE LAPLACE TRANSFORM

• Draw the model, connect the boxes with the arrows depicting where the drug goes.

• The building blocks of the differential rate equations are the arrows and what the tail touches.

• Write the differential rate equation for the box in question. The box is on the left side of the

equal sign and the building blocks are on the other. If the arrow goes away from the box, the

building block is negative, if it is going towards the box, the building block is positive.

• Take the LaPlace Transform of each side of the differential rate equation, using the table where

necessary.

• Algebraically manipulate the transformed equation until an equation having only one trans-

formed dependent variable on the left-hand side is obtained.

• Convert the transformed expression back to the time domain, using the table where necessary to

yield the Integrated equation.

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-53

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.6.5 EXAMPLE INTEGRATION USING THE LAPLACE TRANSFORM

Following an intravenous injection of a drug (bolus dose), its excretion may be

represented by the following pharmacokinetic scheme:

(Scheme I)

Where is the mass of unchanged drug in the body at any time.

is the cumulative mass of unchanged drug in the urine up to any time, and is

the apparent first-order rate constant for excretion of unchanged drug.

Consider how the body excretes a drug

a. The building block is the arrow and what it touches. This first box (compart-

ment) of interest is . The arrow is going out, therefore, the rate is going out

and is negative, thus

(EQ 2-17)

The negative sign indicates loss from the body.

Taking the LaPlace Transform of each side of equation 2-17:

(EQ 2-18)

Note that because the independent variable (time) did not appear on the right-hand

side of equation 2-17, neither did the LaPlace Operator, s, appear there in equation

2-18. All that was necessary was to transform the dependent variable into .

Hence, the table was only required for transforming the left-hand side of equation

2-18.

Manipulating the transformed equation:

1. Get only one variable which changes with time

2. Get on the left and everything else on the right.

X X

u

k

u

X

X

u

k

u

X [ ] k

u

( )

dX

dt

------ - k

u

X – =

sX X

0

– k

u

X – =

X ( ) X

X ( )

X

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-54

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

(EQ 2-19)

(EQ 2-20)

Note that is the only transformed dependent variable and is on the left-hand side

of equation 2-19.

Converting back to the time domain:

(EQ 2-21)

Note that the right-hand side of equation 2-21 was analogous to in the

table, because is a constant (the initial dose administered). The left-hand side

of equation 2-21 could be converted back without the table.

The final expression is the familiar first-order integrated expression.

sX k

u

X + X

0

=

X s k

u

+ ( ) X

0

=

X

X

0

s k

u

+

------------- =

LetX

0

A = Letk

u

a = X

A

s a + ( )

---------------- =

X

X X

0

e

k

u

t –

=

A

s a + ( )

----------------

X

0

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-55

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.6.6 SECOND EXAMPLE INTEGRATION USING THE LAPLACE

TRANSFORM

Look at Scheme I again. Consider how the drug goes from the body into the urine.

The next box of interest is . The arrow is coming in, therefore the rate is com-

ing in and is positive. thus,

(EQ 2-22)

(b) Taking the LaPlace Transform of each side of equation 2-22:

(EQ 2-23)

But, at zero time, the cumulative mass of unchanged drug in the urine was zero:

that is .

(EQ 2-24)

(c) Manipulating the transformed equation:

(EQ 2-25)

Note that there are two transformed dependent variables. One of them can be

replaced by reference to equation 2-19.

(EQ 2-26)

(EQ 2-27)

(d) Converting back to the time domain:

X

u

dX

u

dt

--------- k

u

X =

sX

u

X

u

( )

0

– k

u

X =

X

u

( )

0

0 =

sX

u

k

u

X =

X

u

k

u

X

s

--------- =

X ( )

X

u

k

u

X

0

s s k

u

+ ( )

--------------------- =

Let k

u

X

0

( ) A = Let k

u

( ) a = X

A

s s a + ( )

------------------- =

X

u

k

u

X

0

1 e

k –

u

t

– ( ) ⋅

k

u

---------------------------------------- =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-56

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Where and are analogous to “A” and “a” respectively in the table. Sim-

plifying,

(EQ 2-28)

2.6.7 THIRD EXAMPLE INTEGRATION USING THE LAPLACE TRANSFORM

During the intravenous infusion of a drug, its excretion may be represented by the

following pharmacokinetic scheme:

(Scheme II)

Where Q is the zero-order infusion rate constant (the drug is entering the body at a

constant rate and the rate of change of the mass of drug in the body is governed by

the drug entering the body by infusion and the drug leaving the body by excretion).

The drug entering the body does so at a constant (zero-order) rate.

(EQ 2-29)

(b) Taking the LaPlace Transform of each side of equation 2-29:

Note that because Q is a rate, and is therefore a function of the independent vari-

able (time), its transformation yields the LaPlace Operator. In this case, Q was

analogous to “A” in the table. But, at zero time, the mass of unchanged drug in the

body was zero: that is,

(EQ 2-30)

(c) Manipulating the transformed equation:

(EQ 2-31)

k

u

X

0

k

u

X

u

X

0

1 e

k

u

t –

– ( ) =

X X

u

k

u Q Infusion

dX

dt

------ - Q k

u

X – =

sX X

0

–

Q

s

---- k

u

X – =

X

0

0 =

sX

Q

s

---- k

u

X – =

X

Q

s s k

u

+ ( )

--------------------- =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-57

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

(EQ 2-32)

(d) Converting back to the time domain:

(EQ 2-33)

2.6.8 CONCLUSIONS

The final integrations (Eqs. 24, 24, and 28) are not the ultimate goal of pharmaco-

kinetics. From them come the concepts of:

1. (a) elimination half-life

1. (b) apparent volume of drug distribution

2. (c) plateau drug concentrations

These, and other concepts arising from still other equations, are clinically useful.

Once the method of LaPlace Transforms is mastered, it becomes easy to derive

equations given only the required pharmacokinetic scheme. Under such circum-

stances, it no longer becomes necessary to remember a multitude of equations,

many of which, though very similar, differ markedly in perhaps one minute detail.

As with any new technique, practice is required for its mastery. In this case, mas-

tery will banish the “calculus blues.”

It is also possible to see certain patterns which begin to emerge from the derivation

of the equations. For example, for a drug given by IV bolus the equation is

monoexponential, with the exponent being K, summation of all the ways that the

drug is removed form the body. A graph of the data (Cp v T on semi-log paper)

results in a straight line the slope of which is K, always. If the drug is entirely

metabolized K = km. If the drug is entirely excreted unchanged into the urine, K =

ku. If the drug is metabolized and excreted unchanged into the urine, K = km +ku.

thus K can have different meanings for different drugs, depending on how the

body removes the drug. Following the drug given by IV bolus a second example

of a pattern would be that of the data of the metabolite of the drug. From the

LaPlace, the equation for the plasma concentration of the metabolite of the drug

has in it K and K1, the summation of all the ways that the metabolite is removed

from the body, always. K1 would have different meanings depending on how the

metabolite is removed from the body.

Let Q A = ( ) Let k

u

a = ( ) X

A

s s a + ( )

------------------- =

X

Q 1 e

k –

u

t

– ( )

k

u

----------------------------- =

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-58

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

After several years teaching, I was fortunate to have a resident rotate through our

pharmacokinetic site. She had come with a strong Pharmacokinetcs background

and during our initial meeting, she had told me that she had a copy of John Wag-

ner’s new textbook on pharmacokinetcs. She was excited that, finally, there was a

compilation of all the equations used in pharmacokinetics in one place.

“There are over 500 equations in the new book and I know every one,” she said.

“I’m not sure which one goes with which situation, though.” OOPS!

Throughout this text and on each exam, each equation is derived from first princi-

ples using scientific method, modeling and LaPlace Transforms in the hopes that

memorization will be minimized and thought (and consequently proper interpreta-

tion) would be maximized.

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-59

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.6.9 TABLE OF LAPLACE TRANSFORMS

are constants

are rate constants

is the LaPlace Operator

is a variable, dependent on time

is a power constant

A B ,

a b c , , a b c ≠ ≠ ( )

s

x t ( )

m

TABLE 2-17 Table of LaPlace Transforms

Time Function, LaPlace Transform, F t ( ) f s ( )

A A

s

---

At A

s

2

----

At

m

A m! ( )

s

m 1 +

---------------

Ae

at –

A

s a +

-----------

At

m

e

at –

A

s a + ( )

m 1 +

---------------------------

A 1 e

at –

– ( )

a

--------------------------

A

s s a + ( )

-------------------

At

a

-----

A 1 e

at –

– ( )

a

2

-------------------------- –

A

s

2

s a + ( )

---------------------

Ae

at – B 1 e

at –

– ( )

a

-------------------------- –

As B –

s s a + ( )

-------------------

A

B

a

--- +

. ,

| `

1 e

at –

–

a

------------------

. ,

| `

Bt

a

----- –

As B –

s

2

s a + ( )

---------------------

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-60

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

TABLE 2-17 Table of LaPlace Transforms

Time Function, LaPlace Transform, F t ( ) f s ( )

A e

bt –

e

at –

– ( )

a b – ( )

---------------------------------

A

s a + ( ) s b + ( )

---------------------------------

A

a b – ( )

----------------

1 e

bt –

–

b

------------------

. ,

| `

1 e

at –

–

a

------------------

. ,

| `

–

A

s s a + ( ) s b + ( )

------------------------------------

At

ab

------

A

a b – ( )

----------------

1 e

bt –

–

b

2

------------------

. ,

| `

1 e

at –

–

a

2

----------------- -

. ,

| `

– –

A

s

2

s a + ( ) s b + ( )

--------------------------------------

1

a b – ( )

---------------- B Aa + ( )e

at –

B Ab + ( )e

bt –

– [ ]

As B –

s a + ( ) s b + ( )

---------------------------------

1

a b – ( )

---------------- A e

bt –

e

at –

– ( ) B

1 e

bt –

– ( )

b

----------------------

1 e

at –

– ( )

a

---------------------- –

¹ ¹

' '

¹ ¹

–

As B –

s s a + ( ) s b + ( )

------------------------------------

1

a b – ( )

---------------- A

B

b

--- +

¹ ¹

' '

¹ ¹

1 e

bt –

– ( )

b

---------------------- A

B

a

--- +

¹ ¹

' '

¹ ¹

1 e

at –

– ( )

a

---------------------- –

Bt

ab

------ –

As B –

s

2

s a + ( ) s b + ( )

--------------------------------------

A

e

ct –

a c – ( ) b c – ( )

---------------------------------

e

bt –

a b – ( ) c b – ( )

---------------------------------

e

at –

b a – ( ) c a – ( )

--------------------------------- + +

A

s a + ( ) s b + ( ) s c + ( )

--------------------------------------------------

A

1 e

ct –

– ( )

c a c – ( ) b c – ( )

------------------------------------

1 e

bt –

– ( )

b a b – ( ) c b – ( )

-------------------------------------

1 e

at –

– ( )

a b a – ( ) c a – ( )

------------------------------------ - + +

A

s s a + ( ) s b + ( ) s c + ( )

----------------------------------------------------

At

bc

----- - A

1 e

ct –

– ( )

c

2

a c – ( ) b c – ( )

--------------------------------------

1 e

bt –

– ( )

b

2

a b – ( ) c b – ( )

---------------------------------------

1 e

at –

– ( )

a

2

b a – ( ) c a – ( )

--------------------------------------- + + –

A

s

2

s a + ( ) s b + ( ) s c + ( )

-------------------------------------------------------

dX

dt

-------

sX X

0

–

At

m 1 + ( )

m 1 + ( )

-------------------

A

s

m

-----

Mathematics Review

Basic Pharmacokinetics REV. 00.1.6 2-61

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

2.6.10 LAPLACE TRANSFORM PROBLEMS

By means of the LaPlace Transform, find the equation for:

1. The amount of drug in the body when the drug is given by IV Bolus (assume no metabolism).

2. The amount of drug in the urine when the drug is given by IV Bolus (assume no metabolism).

3. The amount of metabolite in the body when the drug is given by IV Bolus (assume no parent

drug excretion)

4. The amount of metabolite of the drug in the urine when the drug is given by IV Bolus (assume

no parent drug excretion)

5. The amount of metabolite of the drug in the urine when the drug is given by IV Bolus (assume

both parent drug and metabolite excretion)

6. The amount of drug in the body when the drug is given by IV infusion (assume no metabolism).

7. The amount of drug in the urine when the drug is given by IV infusion (assume no metabolism).

8. The amount of metabolite in the body when the drug is given by IV infusion (assume no parent

drug excretion).

9. The amount of metabolite in the urine when the drug is given by IV infusion (assume no parent

drug excretion).

10. The Rate of excretion of the metabolite into the urine for a drug given by IV bolus when

km+ku=kmu.

11. The amount of the principle metabolite (Xm1) when the drug is eliminated by several pathways

(Xu, Xm1,Xm2,Xm3,etc)

12. The concentration of drug, , in the body when the drug is given orally by a delivery system

which is zero order. What is the concentration at equilibrium ( ).

13. The amount of metabolite of a drug in the body when the drug is given by IV Bolus and con-

comitant IV infusion.

14. Disopyramide (D) is a cardiac antiarrythmic drug indicated for the suppression and prevention

of ectopic premature ventricular arrythmias and ventricular tachycardia. It appears that disopy-

ramide is metabolized by a single pathway to mono-dealkylated disopyramide (MND). In a

recent study, the pharmacokinetics of disopyramide were attempted to be elucidated by means

of a radioactive tracer. Since both D and MND would be labeled by the tracer, any equations

showing the time course of the label would show both the D and MND. By means of the

laPlace transform, find the equation for the rate of appearance of tracer into the urine if the drug

were given by IV Bolus.

X

V

d

------

T

∞

Basic Pharmacokinetics REV. 00.1.6 2-62

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

2.6.11 LAPLACE TRANSFORM

SOLUTIONS

1. The amount of drug in the body when the drug is given

by IV bolus (assume no metabolism).

At time zero, all of the IV bolus is in the com-

partment.

Here K = ku

X Xu ku

Dose

X X

o

=

dX

dt

------- k

u

X – =

sX X

0

kuX – = –

sX kuX X

o

= +

X s k

u

+ ( ) X

o

=

X

X

o

s k

u

+

------------- =

Let X

0

( ) A k

u

a X

A

s a + ( )

---------------- = , = , =

X X

o

e

kut –

=

Basic Pharmacokinetics REV. 00.1.6 2-63

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

2. the amount of a drug in the urine when the drug is

given by IV bolus (assume the drug is NOT metabolized

NOTE: You must start where the drug is at time = 0.

Again K = ku

You only need to go this far because you

need to know X to put it in the equation for Xu. Thus:

(X

uo

= 0. No drug in urine at time = 0)

Substituting from above for X.

X Xu

ku

Dose

dX

dt

------- k

u

X – =

sX X

0

kuX – = –

sX kuX X

o

= +

X s k

u

+ ( ) X

o

=

X

X

o

s k

u

+

------------- =

dX

u

dt

--------- k

u

X =

sX

u

X

uo

k

u

X = –

sX

u

k

u

X =

sX

u

X

o

k

u

s k

u

+ ( )

------------------ =

X

u

X

o

k

u

s s k

u

+ ( )

--------------------- =

Let X

0

k

u

( ) A k

u

a = X

u

A

s s a + ( )

------------------- = , , =

X

u

k

u

X

o

1 e

kut –

– ( )

k

u

------------------------------------- =

X

u

X

o

1 e

kut –

– ( ) =

Basic Pharmacokinetics REV. 00.1.6 2-64

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

3. the amount of metabolite of a drug in the body

when the drug is given by IV bolus (assume no parent

drug excretion).

Remember:

You must start where the drug is at time = 0.

Here K = km and K1 = kmu

X

Xm Xmu

km

kmu

Dose

dx

dt

----- - k

m

X – =

sX X

o

k

m

X – = –

sX k

m

X X

o

= +

X s k

m

+ ( ) X

o

=

X

X

o

s k

m

+

-------------- =

Let X

0

( ) A k

m

a X

A

s a + ( )

---------------- = , = , =

X X

o

e

kmt –

=

dX

m

dt

---------- k

m

X = k

mu

X

m

–

sX

m

X

m0

k

m

X k

mu

X

m

– = –

Substituting for X from above

or

in general terms.

NOTE: We could also:

and then

or

Both of those equations are identical.

sX

m

k

m

X

0

s k

m

+

-------------- k

mu

X

m

– =

X

m

k

m

X

o

⋅

s k

mu

+ ( ) s k

m

+ ( )

------------------------------------------ =

Let k

m

X

0

( ) A k

m

a K k

mu

b K1 = = , = = , =

X

m

A

s a + ( ) s b + ( )

--------------------------------- =

X

m

k

m

X ⋅

o

( )

k

m

k

mu

– ( )

------------------------- e

k –

mu

t

e

k –

m

t

– ( ) ⋅ =

X

m

k

m

X ⋅

o

( )

K K1 – ( )

---------------------- e

K – 1t

e

K – t

– ( ) ⋅ =

Let k

m

X

0

( ) A k

m

b k

mu

a = , = , =

X

m

k

m

X ⋅

o

( )

k

mu

k

m

– ( )

------------------------- e

k –

m

t

e

k –

mu

t

– ( ) ⋅ =

X

m

k

m

X ⋅

o

( )

K1 K – ( )

---------------------- e

K – t

e

K1t –

– ( ) ⋅ =

Basic Pharmacokinetics REV. 00.1.6 2-65

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

4. the amount of metabolite of a drug in the urine

when the drug is given by IV bolus (assume the parent

compound is not excreted).

Here, again, K = km and K1 = kmu

substitute previously solved

Remember at time zero,

X

Xm Xmu

km

kmu

Dose

dXm

dt

----------- k

m

X k

mu

X

m

– =

sX

m

X

om

k

m

X k

mu

X

m

– = –

sX

m

k

mu

Xm k

m

X = +

X

X

o

s k

m

+

-------------- =

X

m

s k

mu

+ ( )

k

m

X

o

s k

m

+

-------------- =

X

m

k

m

X

o

s k

mu

+ ( ) s k

m

+ ( )

------------------------------------------ =

X

m

k

m

X

o

e

kmt –

e

kmut –

– ( )

k

mu

k

m

– ( )

--------------------------------------------------- =

dX

mu

dt

------------- k

mu

X

m

=

sX

mu

X

om

k

mu

X

m

= –

X

om

0 =

sX

mu

k

mu

X

m

=

sX

mu

k

mu

( ) k

m

X

o

( )

s k

mu

+ ( ) s k

m

+ ( )

------------------------------------------ =

X

mu

k

mu

( ) k

m

( ) X

o

( )

s s k

mu

+ ( ) s k

m

+ ( )

-------------------------------------------- - =

X

mu

k

mu

k

m

X

o

k

mu

k

m

–

---------------------

1 e

kmt –

–

k

m

---------------------

1 e

kmut –

–

k

mu

----------------------- –

. ,

| `

=

Basic Pharmacokinetics REV. 00.1.6 2-66

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

5. the amount of metabolite of a drug excreted in

the urine when both the parent and metabolite are

excreted.

Here K = km + ku and K1 = kmu

X

Xm Xmu

km

kmu

Dose

Xu ku

dX

dt

------- k

u

X – k

m

X – =

sX X

o

k

u

X – k

m

X – = –

sX k

u

X k

m

X X

o

= + +

X s k

u

k

m

+ + ( ) X

o

=

k

u

k

m

+ ( ) K =

X

X

o

s K +

------------ =

X X

o

e

Kt –

=

dXm

dt

------------ k

m

X k

mu

X

m

k

m

X K1X

m

– = – =

sX

m

X

om

k

m

X K1X

m

– = –

sX

m

K1Xm k

m

X = +

X

m

k

m

X

o

s K1 + ( ) s K + ( )

-------------------------------------- =

dX

mu

dt

------------- k

mu

X

m

=

sX

mu

X

om

k

mu

X

m

K1Xm = = –

sX

mu

K1X

m

=

sX

mu

k

mu

( ) kmX

o

( )

s K1 + ( ) s K + ( )

-------------------------------------- =

X

mu

k

mu

( ) k

m

( ) X

o

( )

s s K1 + ( ) s K + ( )

----------------------------------------- =

X

mu

k

mu

k

m

X

o

K1 K –

----------------------

1 e

Kt –

–

K

-------------------

1 e

K1t –

–

K1

--------------------- –

. ,

| `

=

Basic Pharmacokinetics REV. 00.1.6 2-67

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

6. The amount of drug in the body from a drug given by

IV infusion (assume no metabolism).

At time zero, all the drug is still in the IV bag, therefore

there is no drug in the body. X

0

= 0

Here K = ku

or

X Xu ku

Q

dX

dt

------- Q k

u

X – =

sX X

0

–

Q

s

---- K

u

X – =

sX k

u

X +

Q

s

---- =

X

Q

s s k

u

+ ( )

--------------------- =

X

Q

k

u

----- 1 e

k

u

t –

– ( ) =

X

Q

K

---- 1 e

Kt –

– ( ) =

Basic Pharmacokinetics REV. 00.1.6 2-68

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

7. the amount of drug in the urine when the drug is

given by infusion (assume the drug is NOT metabolized).

Here K = ku

or

X Xu ku

Q

dX

dt

------- Q k

u

X – =

sX X

o

Q

s

---- k

u

X – = –

sX k

u

X

Q

s

---- = +

X s k

u

+ ( )

Q

s

---- = ⋅

X

Q

s s k

u

+ ( ) ⋅

------------------------- =

dX

u

dt

--------- k

u

X =

sX

u

X

o

k

u

X = –

sX

u

k

u

X =

sX

u

k

u

Q

s s k

u

+ ( ) ⋅

------------------------- =

X

u

k

u

Q

s

2

s k

u

+ ( ) ⋅

---------------------------- =

X

u

k

u

Qt

k

u

----------- Qk

u

1 e

kut –

–

k

u

2

--------------------

. ,

| `

– =

X

u

Qt Q

1 e

kut –

– ( )

k

u

------------------------- – = X

u

Qt Q

1 e

Kt –

– ( )

K

----------------------- – =

Basic Pharmacokinetics REV. 00.1.6 2-69

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

8. the amount of metabolite of a drug in the body

from a drug given by IV infusion (assume no parent drug

excretion) Here K = km and K1 = kmu

.

X

Xm Xmu

km

kmu

Q

dX

dt

------- Q k

m

X – =

sX X

o

Q

s

---- k

m

X – = –

sX k

m

X

Q

s

---- = +

X s k

m

+ ( )

Q

s

---- =

X

Q

s s k

m

+ ( )

---------------------- =

X Q

1 e

kmt –

– ( )

k

m

-------------------------- =

dX

m

dt

---------- k

m

X k

mu

X

m

– =

sX

m

X

o

k

m

X k

mu

X

m

– = –

sX

m

k

m

X k

mu

X

m

– =

X

m

k

m

Q

s s k

mu

+ ( ) s k

m

+ ( )

--------------------------------------------- =

or

X

m

A

a b – ( )

---------------- =

1 e

bt –

–

b

------------------

. ,

| `

1 e

at –

–

a

------------------

. ,

| `

–

X

m

k

m

Q

k

mu

k

m

– ( )

------------------------- =

1 e

k

m

t –

–

k

m

--------------------

. ,

| `

1 e

k

mu

t –

–

k

mu

---------------------

. ,

| `

–

X

m

k

m

Q

K1 K – ( )

---------------------- =

1 e

Kt –

–

K

------------------

. ,

| `

1 e

K1t –

–

K1

---------------------

. ,

| `

–

Basic Pharmacokinetics REV. 00.1.6 2-70

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

9. the amount of metabolite of a drug in the urine

from a drug given by IV infusion (assume that the parent

compound is not excreted). Here K = km and K1 = kmu

X

Xm Xmu

km

kmu

Q

dX

dt

------- Q k

m

X – =

sX X

o

Q

s

---- k

m

X – = –

sX k

m

X

Q

s

---- = +

X s k

m

+ ( )

Q

s

---- =

X

Q

s s k

m

+ ( )

---------------------- =

dX

m

dt

---------- k

m

X k

mu

X

m

– =

sX

m

X

o

k

m

X k

mu

X

m

– = –

sX

m

k

mu

X

m

k

m

X = +

X

m

s k

mu

+ ( )

k

m

Q

s s k

m

+ ( )

---------------------- =

X

m

k

m

Q

s s k

m

+ ( ) s k

mu

+ ( )

--------------------------------------------- =

X

m

k

m

Q

k

m

k

mu

–

--------------------

1 e

kmut –

–

k

mu

-----------------------

. ,

| `

1 e

kmt –

–

k

m

---------------------

. ,

| `

– =

substitute

or

dX

mu

dt

------------- k

mu

X

m

=

sX

mu

X

omu

k

mu

X

m

= – X

m

X

mu

k

mu

k

m

Q

s

2

s k

m

+ ( ) s k

mu

+ ( )

----------------------------------------------- =

X

mu

k

mu

k

m

Qt

k

m

k

mu

⋅

----------------------

k

mu

k

m

Q

k

m

k

mu

–

---------------------

. ,

| `

–

1 e

kmut –

– ( )

k

2

mu

-----------------------------

1 e

kmt –

– ( )

k

2

m

-------------------------- –

. ,

| `

=

X

mu

k

mu

k

m

Qt

K1 K ⋅

----------------------

k

mu

k

m

Q

K1 K –

--------------------

. ,

| `

–

1 e

Kt –

– ( )

K

2

------------------------

1 e

K1t –

– ( )

K1

2

-------------------------- –

. ,

| `

=

Basic Pharmacokinetics REV. 00.1.6 2-71

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

10. the rate of excretion of the metabolite into the

urine for a drug given by IV bolus when

In this case, K = ku +km and K1 = kmu and thus K = K1.

This is not normal but could happen. The problem arises

when we get to the LaPlace that assumes the rate con-

stants are different (i.e. ) because for this special

case .

.

k

m

k

u

+ k

mu

=

a b ≠

a b =

X

Xm Xmu

km

kmu

Dose

Xu ku

dX

dt

------- k

u

X – k

m

X – =

sX X

o

k

u

– X k

m

X – = –

sX k

u

X k

m

X X

o

= + +

X s k

u

k

m

+ + ( ) X

o

=

X

X

o

s k

u

k

m

+ + ( )

------------------------------- =

K k

u

k

m

+ ( ) =

k

mu

K1 =

X

X

o

s K + ( )

----------------- =

X X

o

e

Kt –

=

(remember- K1 = K)

(k

m

X

0

= A)

dX

m

dt

---------- k

m

X k

mu

X

m

– ( ) =

sX

m

X

om

k

m

X K1X

m

– ( ) = –

sX

m

K1X

m

k

m

X = +

X

m

s K1 + ( )

k

m

X

o

s K +

------------ =

X

m

k

m

X

o

s K + ( ) s K1 + ( )

-------------------------------------- =

X

m

k

m

X

o

s K1 + ( ) s K1 + ( )

------------------------------------------ =

X

m

k

m

X

o

s K1 + ( )

2

----------------------- =

X

m

k

m

X

o

te

K1t –

=

dX

mu

dt

------------- k

mu

X

m

=

dX

mu

dt

------------- k

mu

k

m

X

o

te

K1t –

=

Basic Pharmacokinetics REV. 00.1.6 2-72

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

11. the principal metabolite when the drug is

cleared by several pathways

In this case K = km1 + km2 + ku, K1 = kmu1 and K2 =

kmu2

Let K = ku + km1 + km2

and

X

m1

( )

X

u

X

m1

X

m2

, , ( )

X

Xm1

Xm2

km1

km2

Xmu1

Xu

Xmu2

ku

kmu1

kmu2

Dose

dX

dt

------- k

u

X – k

m1

X – k

m2

X – =

sX X

o

k

u

X – k

m1

X – k

m2

– X = –

sX k

u

X k

m1

X k

m2

X X

o

= + + +

X s k

u

k

m1

k

m2

+ + + ( ) X

o

=

X

X

o

s K + ( )

----------------- =

K k

u

k

m1

k

m2

+ + ( ) = K1 k

mu1

=

dX

m1

dt

------------- k

m1

X K1X

m1

– =

sX

m1

X

m1o

k

m1

X K1X

m1

– = –

X

m1o

0 =

sX

m1

K1X

m1

k

m1

X

o

s K + ( )

----------------- = +

X

m1

s K1 + ( )

k

m1

X

o

s K + ( )

----------------- =

X

m1

k

m1

X

o

s K1 + ( ) s K + ( )

-------------------------------------- =

X

m1

k

m1

X

o

K K1 –

----------------- e

K1t –

e

Kt –

– ( ) =

Basic Pharmacokinetics REV. 00.1.6 2-73

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

12. the concentration of drug in the body

when the drug is given orally by a delivery system which

is zero order. What is the concentration in the body at

equilibrium

Here K = ku

X Vd ⁄

t

∞

( )

X

Xu

ku Q

Xa

ka

dX

a

dt

--------- Q k

a

X

a

– =

sX

a

X

ao

Q

s

---- k

a

X

a

– = –

X

a0

0 =

sX

a

k

a

X

a

Q s ⁄ ( ) = +

X

a

s k

a

+ ( ) Q s ⁄ ( ) =

X

a

Q

s s k

a

+ ( )

--------------------- =

X

a

Q 1 e

kat –

– ( )

k

a

----------------------------- =

dX

dt

------- k

a

X

a

KX – =

sX X

o

k

a

X

a

KX – = –

X

o

0 =

sX KX

k

a

Q

s s k

a

+ ( )

--------------------- = +

X s K + ( )

k

a

Q

s s k

a

+ ( )

--------------------- =

X

k

a

Q

s s k

a

+ ( ) s K + ( )

--------------------------------------- =

If t= , then , thus

simplified yields:

X

k

a

Q

k

a

K – ( )

------------------- -

1 e

Kt –

) – (

K

------------------------

1 e

kat –

– ( )

k

a

------------------------- –

¹ ¹

' '

¹ ¹

=

C

k

a

Q

k

a

K – ( )Vd

---------------------------

1 e

Kt –

) – (

K

------------------------

1 e

kat –

– ( )

k

a

------------------------- –

¹ ¹

' '

¹ ¹

=

∞ e

kt –

0 = C

k

a

Q

k

a

K – ( )Vd

---------------------------

1

K

----

1

k

a

----- –

¹ ¹

' '

¹ ¹

=

C

Q

KVd

----------- =

Basic Pharmacokinetics REV. 00.1.6 2-74

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

13 the metabolite of a drug in the body given

by IV infusion and concomitant IV bolus dose.

Infusion:

Here K = km and K1 = kmu

Xm

X

Xm Xmu

km

kmu

Q

Dose

dX

dt

------- Q KX – =

sX X

o

Q

s

---- KX – = –

sX KX

Q

s

---- = +

X s K + ( )

Q

s

---- =

X

Q

s s K + ( )

-------------------- =

dX

m

dt

---------- k

m

X K1X

m

– =

sX

m

X

o

k

m

X K1X

m

– = –

sX

m

K1X

m

k

m

X = +

X

m

s K1 + ( )

k

m

Q

s s K + ( )

-------------------- =

X

m

k

m

Q

s s K1 + ( ) s K + ( )

----------------------------------------- =

IV Bolus:

Thus,

X

m

k

m

Q

K K1 – ( )

----------------------

1 e

K1t –

– ( )

K1

--------------------------

1 e

Kt –

– ( )

K

----------------------- –

¹ ¹

' '

¹ ¹

=

dX

dt

------ - KX – =

sX X

o

KX – = –

sX KX X

o

= +

X s K + ( ) X

o

=

X

X

o

s K +

------------ =

dX

m

dt

---------- k

m

X K1X

m

– =

sX

m

X

o

k

m

X K1X

m

– = –

sX

m

K1X

m

k

m

X = +

X

m

s K1 + ( )

k

m

X

o

s K +

------------ =

X

m

k

m

X

o

s K1 + ( ) s K + ( )

-------------------------------------- =

X

m

k

m

X

o

K1 K – ( )

---------------------- e

Kt –

e

K – 1t

– ( ) =

X

m

k

m

X

o

K1 K – ( )

---------------------- e

Kt –

e

K – 1t

– ( )

. ,

| `

… + =

k

m

Q

K1 K –

-----------------

1 e

Kt –

– ( )

K

-----------------------

1 e

K1t –

– ( )

K1

-------------------------- –

¹ ¹

' '

¹ ¹

. ,

| `

Basic Pharmacokinetics REV. 00.1.6 2-75

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/

Mathematics Review

14. By means of the LaPlace transform, find the

equation for the rate of appearance of the tracer in the

urine if the drug were given by IV bolus.

Here K = ku + km and K1 = kmu

X

Xm Xmu

km

kmu

Dose

Xu ku

dX

dt

------- k

u

X – k

m

X – =

sX X

o

k

u

X – k

m

X – = –

sX k

u

X k

m

X X

o

= + +

X s k

u

k

m

+ + ( ) X

o

=

k

u

k

m

+ ( ) K =

X

X

o

s K + ( )

----------------- =

X X

o

e

Kt –

=

dX

u

dt

--------- k

m

X k

u

X

o

e

Kt –

( ) = =

dX

m

dt

---------- k

m

X K1X

m

– =

sX

m

X

o

k

m

X k1X

m

– = –

sX

m

K1X

m

k

m

X

o

s K + ( )

----------------- = +

X

m

s K1 + ( )

k

m

X

o

s K +

------------ =

X

m

k

m

X

o

s K + ( ) s K1 + ( )

-------------------------------------- =

X

m

k

m

X

o

K K1 – ( )

---------------------- e

K1t –

e

Kt –

– { ¦ =

dX

mu

dt

------------- k

mu

X

m

k

mu

k

m

X

o

K K1 – ( )

---------------------- e

K1t –

e

Kt –

– { ¦ = =

dX

u

dt

---------

dX

mu

dt

------------- k

u

X

o

e

Kt –

( )

k

mu

k

m

X

o

K K1 – ( )

----------------------

. ,

| `

e

K1t –

e

Kt –

– { ¦ +

. ,

| `

= +

Banakar pharmacokinetics

Banakar pharmacokinetics

Are you sure?

This action might not be possible to undo. Are you sure you want to continue?

We've moved you to where you read on your other device.

Get the full title to continue

Get the full title to continue listening from where you left off, or restart the preview.

scribd